Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Warning Letter
  6. /
  7. Avlon Industries, Inc.
WARNING LETTER
•Avlon Industries, Inc.•January 24, 2023

Avlon Industries, Inc. – FDA Warning Letter, Jan 24, 2023

Record Details

The FDA issued a Warning Letter to Avlon Industries, Inc. following a January 17-24, 2023 inspection of their Melrose Park, IL drug manufacturing facility, identifying significant Current Good Manufacturing Practice (CGMP) violations. The firm's drug products are deemed adulterated due to non-conforming manufacturing methods, facilities, or controls.

Key violations include: 1. **Failure to test components:** The firm did not conduct identity testing for incoming drug product components (e.g., active ingredients, glycerin, water) and improperly relied on unqualified supplier Certificates of Analysis (COAs). This is particularly critical for high-risk components like glycerin and propylene glycol, which require specific USP identity tests to detect hazardous impurities like diethylene glycol (DEG) or ethylene glycol (EG). 2. **Inadequate production and process controls:** The firm lacked process validation for OTC drug manufacturing, failing to demonstrate reproducibility and consistent quality. They also failed to perform cleaning validation for equipment used for both pharmaceutical and non-pharmaceutical products, a repeat observation from a 2017 inspection. Additionally, the water system used for drug manufacturing was not qualified or adequately monitored, also a repeat observation. 3. **Quality Control Unit (QCU) deficiencies:** The QCU failed to provide adequate oversight, with multiple CGMP-related documents incomplete, indicating a lack of responsibility in ensuring drug product compliance.

The FDA deemed the firm's February

Company
Avlon Industries, Inc.
Inspection date
January 24, 2023
Product type
Drugs
Office
Division of Pharmaceutical Quality Operations III
People
  • Russell K. Riley (Investigator)
  • Jeffrey D. Meng (Associate Director)
View Company Profile

ID · 7bcb8541-b68f-4410-9681-f864d207b559

Violation Codes9
21 U.S.C. 351(a)(2)(B)21 CFR 21021 CFR 21121 CFR 211.84(d)(1)21 CFR 211.84(d)(2)21 CFR 211.100(a)21 CFR 211.100(b)21 CFR 211.2221 CFR 211.34

Full citation text and observation details available on the Dashboard.

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Avlon Industries, Inc.
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.